Developer of an antibody-drug conjugate platform designed to address resistance and improve safety in cancer therapy through novel payload innovation. The company offers new classes of payload mechani...

Healthcare
Marseille, France
Founded 2024
11 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$160.9M
Last Round
N/A